Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Recruitment to activated tyrosine kinase growth factor receptors of Grb2 and p21(ras) leads to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal-regulated kinase (Erk). Activated Erk phosphorylates specific serine residues within cytosolic phospholipase A(2) (PLA(2)), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA). In the A549 human adenocarcinoma cell line dexamethasone inhibited epidermal growth factor (EGF)-stimulated cytosolic PLA(2) (cPLA(2)) activation and AA release by blocking the recruitment of Grb2 to the activated EGF receptor (EGF-R) through a glucocorticoid receptor (GR)-dependent (RU486-sensitive), transcription-independent (actinomycin-insensitive), mechanism. The dexamethasone-induced block of Grb2 recruitment was parallelled by changes in phosphorylation status and subcellular localization of lipocortin 1 (LC1) and an increase in the amount of the tyrosine phosphoprotein co-localized with EGF-R. Like dexamethasone, peptides containing E-Q-E-Y-V from the N-terminal domain of LC1 also blocked ligand-induced association of Grb2, p21(ras) and Raf. Our results point to an unsuspected rapid effect of glucocorticoids, mediated by occupation of GR but not by changes in gene transcription, which is brought about by competition between LC1 and Grb2 leading to a failure of recruitment off signalling factors to EGF-R
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of glucocorticoids to GR not only activates the receptor, but also liberates accessory proteins that participate in secondary signaling cascades.”
From Corticosteroids (2016) · cites this paper as [38]
In the citing paper
“For example, when released from the inactive GR protein complex, c-Src activates signaling cascades that inhibit phospholipase A2 activity, phosphorylate annexin 1, and impair the release of arachidonic acid38, 39.”
From Corticosteroids (2016) · cites this paper as [38]
Citations
Cites
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
cPLA2 is phosphorylated and activated by MAP kinase
Lin, L.-L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A., & Davis, R. J. (1993) · Cell · doi:10.1016/0092-8674(93)90666-e · Cited by 1,849 · cited 1×
“Activated Erk phosphorylates speci®c serine (Ser) residues within cytosolic phospholipase A2 (cPLA2), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA) (Lin et al., 1993).”
BackgroundDNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068 · cited 1×
“A recent study, for example, showed that, in contrast to the lethal nature of a GR knock-out, mice bearing a mutation of the GR which disabled dimerization, and hence GRE binding, survived (Reichardt et al., 1998).”
ResultTyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959 · cited 1×
“Moreover, direct regulation of signalling mechanisms also appears to be a feature of the action of other steroid receptors, such as that for oestradiol (Migliaccio et al., 1996), and other nuclear hormone receptors (Bost et al., 1997).”
BackgroundMolecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889 · cited 1×
“The unactivated (unligated) GR is retained in the cytoplasm as a multi-protein complex consisting of heat shock proteins (hsp) (Bamberger et al., 1996) and several kinases of the MAPK signalling system, including Src (Pratt, 1998).”
BackgroundHeck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P., & Cato, A. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06726.x · Cited by 522 · cited 1×
“The inference was that other transcriptional activators such as AP1 and NFkB, which are probably bound by the GR monomer (Heck et al., 1994), play a key role in mediating the action of glucocorticoids.”
BackgroundMultiple components in an epidermal growth factor-stimulated protein kinase cascade
Ahn, N. G., Seger, R., Bratlien, R. L., Diltz, C. D., Tonks, N. K., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64310-1 · Cited by 492
Pratt, W. B. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44252 · Cited by 447 · cited 12×
“We show here that both GR and Src are rapidly released from the hsp90 complex in A549 cells following treatment by dexamethasone.”
BackgroundInfluentialInvolvement of p21ras in activation of extracellular signal-regulated kinase 2
de Vries-Smits, A. M. M., Burgering, B. M. T., Leevers, S. J., Mar shall, C. J., & Bos, J. L. (1992) · Nature · doi:10.1038/357602a0 · Cited by 387 · cited 1×
“…adapter protein Grb2 and the small GTPase p21ras initiates transduction of the mitogenic signalling mechanisms leading to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal-regulated kinase (Erk) (Ahn et al., 1991; de Vries-Smits et al., 1992).”
BackgroundNuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
Caelles, C., González-Sancho, J. M., & Muñoz, A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3351 · Cited by 334 · cited 1×
“Recently, other groups have implicated Jnk as an important mediator in A549 cell proliferation (Bost et al., 1997) and suggested that there is cross-talk between this pathway and activation of nuclear hormone receptors (Caelles et al., 1997).”
Background
Cited by
Items 101–200 of 330
Yukawa, H., Shen, J., Harada, N., Cho-Tamaoka, H., & Yamashita, T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.037 · Cited by 60
Kinome Analysis Reveals Nongenomic Glucocorticoid Receptor-Dependent Inhibition of Insulin Signaling
Löwenberg, M., Tuynman, J. B., Scheffer, M., Verhaar, A. P., Vermeulen, L., van Deventer, S. J. H., Hommes, D. W., & Peppelenbosch, M. P. (2006) · Endocrinology · doi:10.1210/en.2005-1602 · Cited by 70
Widén, C., Zilliacus, J., Gustafsson, J.-Α., & Wikström, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006943200 · Cited by 67
Implications of glucocorticoid therapy in idiopathic inflammatory myopathies
Hanaoka, B. Y., Peterson, C. A., Horbinski, C., & Crofford, L. J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.85 · Cited by 57
Glucocorticoids promote Von Hippel Lindau degradation and Hif-1α stabilization
Vettori, A., Greenald, D., Wilson, G. K., Peron, M., Facchinello, N., Markham, E., Mathavan, S., Matthews, L. C., McKeating, J. A., Argenton, F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705338114 · Cited by 61
Glucocorticoids for Human Skin: New Aspects of the Mechanism of Action
Schäfer-Korting, M., Kleuser, B., Ahmed, M., Höltje, H.-D., & Korting, H. C. (2005) · Skin Pharmacology and Physiology · doi:10.1159/000084907 · Cited by 56
“Glucocorticoids inhibit the recruitment of signalling factors of activated epithelial growth factor receptors and thus phospholipase A 2 and arachidonic acid release [”
BackgroundChivers, J. E., Cambridge, L. M., Catley, M. C., Mak, J., Donnelly, L., Barnes, P. J., & Newton, R. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04342.x · Cited by 62
“attributable to a partial agonistic effect of RU486 acting alone [25].”
BackgroundInfluentialKfir‐Erenfeld, S., Sionov, R. V., Spokoini, R., Cohen, O., & Yefenof, E. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.506570 · Cited by 61
“This scenario resembles the observation that Src is released from Hsp90 complexes after GC treatment in A549 lung adenocarcinoma cells [19].”
Background11β-Hydroxysteroid dehydrogenases, cell proliferation and malignancy
Rabbitt, E. H., Gittoes, N. J. L., Stewart, P. M., & Hewison, M. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00224-3 · Cited by 63
Minireview: Role of Kinases and Chromatin Remodeling in Progesterone Signaling to Chromatin
Vicent, G. P., Nacht, A. S., Zaurín, R., Ballaré, C., Clausell, J., & Beato, M. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0027 · Cited by 54
Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application
Längericht, J., Kramer, I. F., & Kahaly, G. J. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820958335 · Cited by 61
Rapid neuromodulation by cortisol in the rat paraventricular nucleus: an in vitro study
Zaki, A., & Barrett‐Jolley, R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704832 · Cited by 52
“More rapid GR mediated activity has also been reported (Croxtall et al., 2000), but to date, all cortisol responses resulting from interaction with GR have proven sensitive to the GR antagonist, mifepristone (also known as `RU38486', or `RU486', Gagne et al., 1985; Moguilewsky & Philibert, 1984).”
BackgroundMulla, A., Christian, H., Solito, E., Mendoza, N., Morris, J. F., & Buckingham, J. C. (2003) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01936.x · Cited by 50
“Studies investigating the role of ANXA1 in EGF-stimulated cell growth in carcinoma cell lines have indicated that phosphorylation of ANXA1 at the tyrosine residue in position 21 is important in this regard (Croxtall et al., 2000; de Coupade et al., 2000).”
BackgroundRabbitt, E. H., Ayuk, J., Boelaert, K., Sheppard, M. C., Hewison, M., Stewart, P. M., & Gittoes, N. J. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206293 · Cited by 56
Grzanka, A., Misiołek, M., Golusiński, W., & Jarząb, J. (2010) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-010-1330-z · Cited by 57
“Nongenomic GC effects can also be dependent on GC affinity to its receptor [23].”
BackgroundHayes, M. J., Longbottom, R. E., EVANS, M. A., & Moss, S. E. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_1 · Cited by 56
Spies, C. M., Schaumann, D., Berki, T., Mayer, K., Jakstadt, M., Huscher, D., Wunder, C., Burmester, G. R., Radbruch, A., Lauster, R., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048272 · Cited by 57
Nakamura, T., Fujiwara, R., Ishiguro, N., Oyabu, M., Nakanishi, T., Shirasaka, Y., Maeda, T., & Tamai, I. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.691 · Cited by 48
Non-genomic signaling of steroid receptors in cancer
Thiébaut, C., Vlaeminck‐Guillem, V., Trédan, O., Poulard, C., & Romancer, M. L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111453 · Cited by 56
“However, GR and Src are rapidly dissociated from HSP90 after dex treatment in A549 cells (Croxtall et al., 2000) and BC”
Glucocorticoid receptor signaling in the brain and its involvement in cognitive function
Su, C., Huang, T., Zhang, M., Zhang, Y., Zeng, Y., & Chen, X. Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00355 · Cited by 57
11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
Morgan, S., & Tomlinson, J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.504713 · Cited by 51
“Furthermore, some GC effects have been reported to occur within minutes, and are insensitive to transcriptional inhibition [15-17].”
Pharmacology of intra-articular triamcinolone
Scherer, J., Rainsford, K. D., Kean, C. A., & Kean, W. F. (2014) · Inflammopharmacology · doi:10.1007/s10787-014-0205-0 · Cited by 52
Annexin A1: Novel roles in skeletal muscle biology
Bizzarro, V., Petrella, A., & Parente, L. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.24032 · Cited by 48
“This mechanism requires a signalling cascade involving protein kinase C (PKC) and other kinases leading to ANXA1 phosphorylation (Croxtall et al., 2000; Solito et al., 2003).”
BackgroundNuñez, F. J., Johnstone, T. B. C., Corpuz, M. L., Kazarian, A. G., Mohajer, N. N., Tliba, O., Panettieri, R. A., Koziol‐White, C. J., Roosan, M. R., & Ostrom, R. S. (2019) · The FASEB Journal · doi:10.1096/fj.201902521r · Cited by 48
Treating gliomas with glucocorticoids: from bedside to bench
Piette, C., Munaut, C., Foidart, J., & Deprez, M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0100-x · Cited by 56
“... is the case in the A549 human adenocarcinoma cell line, where, after epidermal growth factor receptor (EGFR) activation, dexamethasone inhibits the MAPK-dependent activation of cPLA2 and the subsequent release of arachidonic acid (Fig. 2). This eVect is mediated through dexamethasone-induced phosphorylation of ANX…”
BackgroundJohn, C. D., Christian, H. C., Morris, J. F., Flower, R. J., Solito, E., & Buckingham, J. C. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.01081.x · Cited by 44
Self-citationYazid, S., Sinniah, A., Solito, E., Calder, V. L., & Flower, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058963 · Cited by 43
“This GC-induced secretory event is preceded by phosphorylation at Ser (and other sites), apparently as a result of PKC activation [41–43] by a glucocorticoid receptor (GR)-dependent mechanism.”
BackgroundSelf-citationTraditional therapies: glucocorticoids, azathioprine, methotrexate, hydroxyurea
Belgi, G., & Friedmann, P. S. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.01146.x · Cited by 43
Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1
Yazid, S., Solito, E., Christian, H., McArthur, S., Goulding, N. J., & Flower, R. J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.010 · Cited by 46
Self-citationGonzález, R., Ruiz‐León, Y., Gomendio, M., & Roldán, E. R. S. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.10.009 · Cited by 35
Pharmacodynamics of glucocorticoids.
Strehl, C., Spies, C. M., & Buttgereit, F. (2011) · PubMed · Cited by 52
Glucocorticoid Signaling and the Aging Heart
Cruz‐Topete, D., Oakley, R. H., & Cidlowski, J. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00347 · Cited by 46
Glucocorticoid resistance — what is known?
Norman, M., & Hearing, S. D. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00232-1 · Cited by 41
Zhang, J., Ge, P., Liu, J., Luo, Y., Guo, H., Zhang, G., Xu, C., & Chen, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512138 · Cited by 47
The current relevance and use of prednisone in rheumatoid arthritis
Krasselt, M., & Baerwald, C. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.904746 · Cited by 39
“, Src) as part of the multireceptor complex providing a nongenomic inhibition of arachidonic acid release [29,99,100]”
BackgroundCardiac glycogen accumulation after dexamethasone is regulated by AMPK
Puthanveetil, P., Wang, F., Kewalramani, G., Kim, M. S., Hosseini‐Beheshti, E., Ng, N., Lau, W., Pulinilkunnil, T., Allard, M. F., Abrahani, A., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.518.2008 · Cited by 43
“These include a specific cytosolic receptor-mediated event and specific and nonspecific membrane-bound receptor-mediated effects through which glucocorticoids bring about genomic and nongenomic outcomes (8, 10, 11).”
BackgroundGekle, M., Freudinger, R., Mildenberger, S., & Silbernagl, S. (2002) · Steroids · doi:10.1016/s0039-128x(01)00183-0 · Cited by 38
Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 39
Annexin 1: A glucocorticoid‐inducible protein that modulates inflammatory pain
Chen, L., Lv, F., & Pei, L. (2014) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00373.x · Cited by 35
“Meanwhile, exogenous dexamethasone and endogenous steroids induced by inflammation can rapidly increase membrane tanslocation level of ANXA1 (Croxtall et al., 2000; Solito et al., 2006), through the mechanisms of de novo protein synthesis.”
BackgroundArango-Lievano, M., & Jeanneteau, F. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.005 · Cited by 41
Transcriptional Regulation of Human Transforming Growth Factor-α in Astrocytes
Karki, P., Johnson, J., Son, D., Aschner, M., & Lee, E.-S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9705-9 · Cited by 35
“It has also been suggested that non-genomic steroid actions may activate MAPK and other signaling cascades possibly via stimulation of the classical intracellular receptors [71].”
The Anti-allergic Cromones: Past, Present, and Future
Sinniah, A., Yazid, S., & Flower, R. J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00827 · Cited by 34
“, macrophages), glucocorticoids have not only been found to promote Anx-A1 synthesis through genomic action, but also to trigger the rapid release of pre-existing pools of AnxA1 from the cell cytoplasm (Croxtall et al., 2000).”
Self-citationPérez, M. H., Cormack, J., Mallinson, D. J., & Mutungi, G. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.256586 · Cited by 41
“…rapid/non-genomic effects in guinea pig neurones (Hua & Chen, 1989), human endometrial cells (Koukouritaki et al. 1997), human adenocarcinoma cells (Croxtall et al. 2000), rat thymocytes (Buttgereit et al. 1997) and airway vasculature (Wanner et al. 2004), this is the first study to demonstrate…”
BackgroundInfluentialRadke, S., Austermann, J., Russo‐Marie, F., Gerke, V., & Rescher, U. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.078 · Cited by 34
Wehmeyer, L., Toit, A. D., Lang, D. M., & Hapgood, J. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544742 · Cited by 37
Genomic and non-genomic effects of different glucocorticoids on mouse thymocyte apoptosis
Bruscoli, S., Virgilio, R. D., Donato, V., Velardi, E., Baldoni, M., Marchetti, C., Migliorati, G., & Riccardi, C. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.053 · Cited by 36
Nuclear receptors in neural stem/progenitor cell homeostasis
Gkikas, D., Tsampoula, M., & Politis, P. K. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2571-4 · Cited by 33
Glucose Metabolism in Burns—What Happens?
Bădoiu, S. C., Miricescu, D., Stănescu-Spînu, I.-I., Totan, A., Badoiu, S. E., Costagliola, M., & Greabu, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105159 · Cited by 38
“These are usually anti-inflammatory and immunosuppressive effects [80,82,83].”
BackgroundModulation of Aspirin-Insensitive Eicosanoid Biosynthesis by 6-Methylprednisolone in Unstable Angina
Cipollone, F., Ganci, A., Greco, A., Panara, M. R., Pasquale, M., Gregorio, D. D., Porreca, E., Mezzetti, A., Cuccurullo, F., & Patrignani, P. (2003) · Circulation · doi:10.1161/01.cir.0000043260.82447.62 · Cited by 34
Jain, A., Wordinger, R. J., Yorio, T., & Clark, A. F. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0239 · Cited by 36
The impact of genetic factors on response to glucocorticoids therapy in IBD
Gabryel, M., Skrzypczak-Zielińska, M., Kucharski, M., Słomski, R., & Dobrowolska, A. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1132336 · Cited by 35
“[83,84] GCs inhibit the development of inflammation, also through other ways than the influence on gene expression – they favor the discharge of Src kinase in the cytoplasm, which results in the activation of lipocortin, inhibition of arachidonic acid release,[85] and change in the cytoplasmic iron level.”
BackgroundKawaminami, M., Shibata, Y., Yaji, A., Kurusu, S., & HASHIMOTO, I. (2003) · Endocrinology · doi:10.1210/en.2003-0118 · Cited by 31
“Overexpression of annexins 1 and 5 was shown to down-regulate the MAPK/ERK pathway (4, 40), and the phosphorylation of annexin 1 was revealed to block ligand-induced association of Grb2, p21(ras), and Raf in the A549 human adenocarcinoma cell line (41).”
BackgroundUtility of Targeted Glucocorticoids in Cancer Therapy
Banciu, M., Schiffelers, R. M., Metselaar, J. M., & Storm, G. (2008) · Journal of Liposome Research · doi:10.1080/08982100801893978 · Cited by 31
Demir, A. Y., Demol, H., Puype, M., de Goeij, A. F. P. M., Dunselman, G. A. J., Herrler, A., Evers, J. L. H., Vandekerckhove, J. S., & Groothuis, P. G. (2004) · PROTEOMICS · doi:10.1002/pmic.200300827 · Cited by 30
Pawlak, K. J., Zhang, G., & Wiebe, J. P. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.05.014 · Cited by 30
Li, Y., Zhang, Y., Wang, X., Yang, Q., Zhou, X., Wu, J., Xu, Y., Zhao, Y., Lin, R., Xie, Y., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02137-x · Cited by 29
“When EGFR and Annexin A2 proteins are simultaneously highly expressed in human glioma cells, the role of the MAPK signaling pathway is significantly enhanced, promoting the aggressive growth of human glioma cells [38].”
BackgroundPKCδ‐dependent cleavage and nuclear translocation of annexin A1 by phorbol 12‐myristate 13‐acetate
Kim, Y. S., Ko, J., Kim, I. S., Jang, S., Sung, H. J., Lee, H. J., Lee, S. Y., Kim, Y., & Na, D. S. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03800.x · Cited by 29
Rapid Corticosteroid Actions on Behavior
Orchinik, M., Gasser, P., & Breuner, C. W. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50053-6 · Cited by 33
Human immune deficiency virus (HIV) infection and the hypothalamic pituitary adrenal axis
George, M. M., & Bhangoo, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9244-x · Cited by 30
Dexamethasone-induced cardioprotection: A role for the phosphatase MKP-1?
Fan, W.-J., Genade, S., Genis, A., Huisamen, B., & Lochner, A. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.03.014 · Cited by 28
Scheving, L. A., Buchanan, R., Krause, M. A., Zhang, X., Stevenson, M. C., & Russell, W. E. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00140.2007 · Cited by 29
“The phosphorylated lipocortin binds to GrbB2 docking sites on EGFr, thereby inhibiting the transmission of signals necessary for EGF-stimulated arachidonic acid release and cell growth (12).”
BackgroundKoziol‐White, C. J., Jia, Y., Baltus, G. A., Cooper, P. R., Zaller, D. M., Crackower, M. A., Sirkowski, E. E., Smock, S. L., Northrup, A. B., Himes, B. E., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13550 · Cited by 26
“Whether corticosteroids directly modulate humanmast cell function remains controversial (Croxtall et al., 2000; Liu et al., 2007; Zhou et al., 2008).”
BackgroundRole of annexin 1 gene expression in mouse craniofacial bone development
Damazo, A. S., Moradi‐Bidhendi, N., Oliani, S. M., & Flower, R. J. (2007) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20368 · Cited by 27
Self-citationBoncompagni, S., Arthurton, L., Akujuru, E. E., Pearson, T., Steverding, D., Protasi, F., & Mutungi, G. (2015) · The Journal of Physiology · doi:10.1113/jp270502 · Cited by 32
“2002), human adenocarcinoma cells (Croxtall et al. 2000), rat thymocytes (Buttgereit et al.”
BackgroundSpatial expression of two anti‐inflammatory mediators, annexin 1 and galectin‐1, in nasal polyposis
Sena, A. A. S., Provazzi, P. J. S., Fernandes, A. M., Cury, P. M., Rahal, P., & Oliani, S. M. (2006) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2006.02570.x · Cited by 25
Michaux, G., Magerl, W., Anton, F., & Treede, R. (2011) · Pain · doi:10.1016/j.pain.2011.10.043 · Cited by 23
“Nongenomic action of glucocorticoids can operate within minutes and is mediated by binding to specific glucocorticoid membrane receptors, and may lead to rapid suppression of intracellular signal cascades—for example, mediated via phospholipase A2 [11].”
BackgroundGlucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy
Berardicurti, O., Ruscitti, P., Pavlych, V., Conforti, A., Giacomelli, R., & Cipriani, P. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1772055 · Cited by 26
Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system
Yazid, S., Norling, L. V., & Flower, R. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.11.005 · Cited by 27
Self-citationDexamethasone induces rapid tyrosine-phosphorylation of ZAP-70 in Jurkat cells
Bartis, D., Boldizsár, F., Szabó, M., Pàlinkàs, L., Németh, P., & Berki, T. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.01.032 · Cited by 27
Tong, M., & Tai, H. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.11.031 · Cited by 23
Wang, K., Chen, Z., Long, L., Tao, Y., Wu, Q., Xiang, M., Liang, Y., Xie, X., Jiang, Y., Xiao, Z., et al. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1472192 · Cited by 22
“to the src homology domain can bind the linker protein Grb-2, which regulates multiple signaling pathways, thereby regulating cell proliferation.(85) Initial studies have reported that ANXA1 binds to EGF receptors and regulates cell proliferation.”
BackgroundInhibitory effects of glucocorticoids on rat eosinophil superoxide generation and chemotaxis
Sugimoto, Y., Ogawa, M., 宣之, 田., & Kamei, C. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00055-9 · Cited by 22
ErbB2 and EGFR are downmodulated during the differentiation of 3T3‐L1 preadipocytes
Pagano, E. S., & Calvo, J. C. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10647 · Cited by 23
“Dexamethasone, by glucocorticoid receptor occupation, has been described to cause a rapid inhibition of signaling proteins recruitment to EGFR, thus leading to decrease its mitogenic signal [Croxtall et al., 2000].”
BackgroundEndogenous Annexin-A1 Negatively Regulates Mast Cell-Mediated Allergic Reactions
Sinniah, A., Yazid, S., Bena, S., Oliani, S. M., Perretti, M., & Flower, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01313 · Cited by 21
Self-citationYamagata, S., Tomita, K., Sano, H., Itoh, Y., Fukai, Y., Okimoto, N., Watatani, N., Inbe, S., Miyajima, H., Tsukamoto, K., et al. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04636.x · Cited by 19
Topical Corticosteroids: Pharmacology
Kwatra, G., & Mukhopadhyay, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-4609-4_2 · Cited by 21
“Non-genomic glucocorticoid effects could mediate non-genomic effects on immune cells [25].”
BackgroundKydd, A. S., Achari, Y., Lu, T., Sciore, P., Rattner, J. B., & Hart, D. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.05.001 · Cited by 25
MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation
Kayahara, M., Ohanian, J., Ohanian, V., Berry, A. A., Vadlamudi, R. K., & Ray, D. W. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90429.2008 · Cited by 21
The link between stress and the efficacy of anxiolytics. A new avenue of research
Haller, J. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00452-8 · Cited by 22
Gene expression-based screening for inhibitors of PDGFR signaling
Antipova, A. A., Stockwell, B. R., & Golub, T. R. (2008) · Genome biology · doi:10.1186/gb-2008-9-3-r47 · Cited by 21
“Activated ERK phosphorylates phospholipase A2 [15], and as a result”
BackgroundZhang, N., Crombruggen, K. V., Holtappels, G., Lan, F., Katotomichelakis, M., Zhang, L., Högger, P., & Bachert, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093754 · Cited by 19
Horváth, G., Vasas, S., & Wanner, A. (2006) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2006.03.009 · Cited by 18
“These rapid actions are initiated by actions on membrane-bound [13, 14] or cytoplasmic receptors [15, 16], or nonspecific interactions with the cell membrane [17].”
BackgroundAnnexin1 regulates the erythroid differentiation through ERK signaling pathway
Huo, X.-F., & Zhang, J.-W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.049 · Cited by 19
A novel strategy for development of glucocorticoids through non-genomic mechanism
Zhou, J., Li, M., Sheng, C., Liu, L., Li, Z., Wang, Y., Zhou, J., Jing, Z., Chen, Y., & Jiang, C. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0526-0 · Cited by 20
Malcher‐Lopes, R., & Buzzi, M. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81011-x · Cited by 25
Kydd, A. S., Reno, C. R., Tsao, H. W., & Hart, D. A. (2007) · PubMed · Cited by 20
Konishi, Y., Sato, H., & Tanaka, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.032 · Cited by 18
Management of Moderately Severe Graves’Orbitopathy
Kahaly, G. J. (2007) · KARGER eBooks · doi:10.1159/000107455 · Cited by 17
Les glucocorticoïdes et leur récepteur : mécanismes d'action et conséquences cliniques
Roumestan, C., Gougat, C., Jaffuel, D., & Mathieu, M. (2004) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2004.01.012 · Cited by 34
Knych, H. K. D., Vidal, M. A., Chouicha, N., Mitchell, M., & Kass, P. H. (2015) · Equine Veterinary Journal · doi:10.1111/evj.12531 · Cited by 18
“ANAX-1 subsequently inhibits PLA2, preventing the release of arachidonic acid [31,32].”
BackgroundConserved Steroid Hormone Homology Converges on Nuclear Factor κB to Modulate Inflammation in Asthma
Payne, A. S., & Freishtat, R. J. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31823d7989 · Cited by 20
“Within minutes, glucocorticoids inhibit Mek1 and Erk1, members of MAPK pathways.(38) Similarly, the rapid effects of estrogen include activation of signaling cascades leading to ion fluxes and activation of kinases and phosphatases or other second messengers via G proteinY coupled receptors.”
BackgroundGlucocorticoid Receptor Localizes to Adherens Junctions at the Plasma Membrane of Keratinocytes
Stojadinović, O., Sawaya, A. P., Pastar, I., & Tomic‐Canic, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063453 · Cited by 22
“GR regulates multiple signaling pathways including MAPK, cAMP-PKA, PI3K, and PLC-PKC pathways in a variety of tissue types such as neuronal and erythroid cells [8,11,12].”
Wendt, E., White, G. E., Ferry, H., Hühn, M. H., Greaves, D. R., & Keshav, S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500619 · Cited by 18
Rapid Selective Priming of FcαR on Eosinophils by Corticosteroids
ten Hove, W., Houben, L. A. M. J., Raaijmakers, J. A. M., Koenderman, L., & Bracke, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6108 · Cited by 16
Systemic Complications of Complex Regional Pain Syndrome
Schwartzman, R. J. (2012) · Neuroscience & Medicine · doi:10.4236/nm.2012.33027 · Cited by 16
“Glucocorticoids may decrease pain by several mechanisms: 1) Suppression of intracellular cascades mediated by phospholipase A2 [163]; 2) Decreasing ectopic discharge from experimental neuromas; 3) Blocking neurotransmission in C fibers [164,165]; 4) Decreasing microglial activation [166].”
BackgroundRevisiting steroid treatment for septic shock: molecular actions and clinical effects - a review
Japiassú, A. M., Salluh, J. I., Bozza, P. T., Bozza, F. A., & Castro-Faria-Neto, H. C. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000400001 · Cited by 22
“…explain the rapid anti-inflammatory and immunosuppressive effects of corticosteroids that are not compatible with the genomic mechanism of action (Croxtall et al. 2000, Buttgereit & Scheffold 2002, Hafezi-Moghadam et al. 2002): (i) non-specific interactions of corticosteroids with cellular…”
BackgroundInfluentialCalcineurin phosphatase activity: activation by glucocorticoids and role of intracellular calcium1
Tong, D. C., Buck, S. M., Roberts, B. R., Klein, J. D., & Tumlin, J. A. (2004) · Transplantation · doi:10.1097/01.tp.0000099267.05131.11 · Cited by 15
“However, recent studies have shown that glucocorticoids and other steroid hormones exhibit rapid and transcription-independent effects that do not conform to this model (2).”
BackgroundJahan, A., Shams, S., Ali, S., Samrana, S., Ali, A., Adhikari, A., Sajid, M., Ali, A., & Ali, H. (2021) · ACS Omega · doi:10.1021/acsomega.0c02261 · Cited by 16
Lin, T., Liu, J., Yang, S., Liu, X., Feng, X., & Fu, D. (2016) · Indian Journal of Orthopaedics · doi:10.4103/0019-5413.185606 · Cited by 14
D’Attlio, L., Trini, E., Bongiovanni, B., Dídoli, G., Gardeñez, W., Nannini, L. J., Giri, A. A., Bottasso, O. A., & Bay, M. L. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.11.006 · Cited by 15
Metadata
- Authors
- Croxtall, J. D., Choudhury, Q., & Flower, R. J.
- Affiliations
- Queen Mary University of London (GB)
- Corresponding author
- Croxtall, Jamie D
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-05
- Volume
- 130
- Issue
- 2
- Pages
- 289-298
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572055
- OpenAlex
- W2076179697
- Cited by
- 332
- References
- 42
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 12 · 2014: 15 · 2013: 18 · 2012: 17
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoids, dexamethasone, epidermal growth factor receptor, Grb2, p21ras, Raf, ERK signaling, cytosolic phospholipase A2, arachidonic acid release, annexin A1, glucocorticoid receptor, receptor tyrosine kinase signaling, A549 cells
- MeSH terms
- Binding, Competitive, Dexamethasone, Enzyme Activation, Glucocorticoids, Humans, Phospholipases A, Phosphorylation, Protein Conformation, Proteins, Receptors, Glucocorticoid, Transcription, Genetic, Tumor Cells, Cultured, Signal Transduction, Annexin A1, MAP Kinase Signaling System, Adaptor Proteins, Signal Transducing, GRB2 Adaptor Protein, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.